Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lewis Acid Catalyzed Demethylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced demethylation process for 4-deoxy daunorubicin intermediates. Reduces impurities and enhances scalability for reliable pharmaceutical intermediate supply chains.
Patent CN111170886B details a novel mild oxidation and demethylation route for dezocine impurities, ensuring high purity and scalable pharmaceutical intermediate manufacturing.
Patent CN106977377B reveals a one-pot Lewis acid method for 7-hydroxy-1-tetralone, offering high purity and eliminating phosphorus waste for reliable pharmaceutical intermediate supply chains.
Patent CN112010913B reveals a scalable MgCl2-mediated demethylation for 4-deoxy daunorubicin intermediates, offering reduced impurities and enhanced supply chain reliability for pharmaceutical manufacturers.
Patent CN107118128B details a high-yield synthesis of 3,4-dihydroxybenzonitrile from vanillin using Lewis acid demethylation, offering cost-effective pharmaceutical intermediate manufacturing.
Novel AlCl3-catalyzed demethylation route improves purity and yield. Ideal for reliable phloroglucinol supplier seeking cost reduction in pharmaceutical intermediates manufacturing.